Bleakley Financial Group LLC Has $5.55 Million Position in Nutrien Ltd. $NTR

Bleakley Financial Group LLC raised its holdings in Nutrien Ltd. (NYSE:NTRFree Report) by 19.0% during the first quarter, Holdings Channel.com reports. The fund owned 73,498 shares of the company’s stock after purchasing an additional 11,739 shares during the period. Bleakley Financial Group LLC’s holdings in Nutrien were worth $5,546,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in NTR. Guggenheim Capital LLC lifted its stake in shares of Nutrien by 2.2% in the 4th quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock valued at $409,000 after purchasing an additional 145 shares during the period. Minot DeBlois Advisors LLC boosted its position in shares of Nutrien by 1.8% in the 4th quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock worth $557,000 after purchasing an additional 164 shares during the last quarter. Banque Cantonale Vaudoise grew its stake in shares of Nutrien by 15.9% during the first quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock worth $90,000 after purchasing an additional 164 shares during the period. EverSource Wealth Advisors LLC grew its stake in shares of Nutrien by 21.8% during the fourth quarter. EverSource Wealth Advisors LLC now owns 983 shares of the company’s stock worth $61,000 after purchasing an additional 176 shares during the period. Finally, Assenagon Asset Management S.A. increased its holdings in Nutrien by 1.2% in the first quarter. Assenagon Asset Management S.A. now owns 15,822 shares of the company’s stock valued at $1,191,000 after purchasing an additional 183 shares during the last quarter. Institutional investors own 63.10% of the company’s stock.

Nutrien Stock Performance

NTR stock opened at $68.65 on Wednesday. Nutrien Ltd. has a 1-year low of $53.03 and a 1-year high of $85.36. The company has a current ratio of 1.24, a quick ratio of 0.59 and a debt-to-equity ratio of 0.35. The firm has a market cap of $32.90 billion, a PE ratio of 13.98, a P/E/G ratio of 0.65 and a beta of 0.62. The business’s 50-day moving average price is $67.05 and its two-hundred day moving average price is $69.80.

Nutrien (NYSE:NTRGet Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.03. The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.30 billion. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The company’s revenue for the quarter was up 18.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.11 earnings per share. As a group, research analysts forecast that Nutrien Ltd. will post 5.19 earnings per share for the current year.

Nutrien Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 17th. Investors of record on Tuesday, June 30th will be given a $0.55 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.20 annualized dividend and a dividend yield of 3.2%. Nutrien’s payout ratio is currently 44.81%.

Wall Street Analysts Forecast Growth

NTR has been the topic of several analyst reports. Berenberg Bank set a $65.00 target price on Nutrien and gave the company a “hold” rating in a research note on Wednesday, June 10th. Morgan Stanley decreased their target price on Nutrien from $93.00 to $81.00 and set an “overweight” rating for the company in a research report on Tuesday, July 7th. Scotiabank raised Nutrien from a “sector perform” rating to a “sector outperform” rating and set a $80.00 price target for the company in a research note on Tuesday, June 30th. Royal Bank Of Canada increased their price target on shares of Nutrien from $80.00 to $85.00 and gave the company an “outperform” rating in a research report on Tuesday, April 7th. Finally, Wall Street Zen lowered shares of Nutrien from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. Fourteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Nutrien currently has an average rating of “Moderate Buy” and a consensus price target of $82.00.

Get Our Latest Research Report on Nutrien

About Nutrien

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

See Also

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.